16 participants
A Basket Trial of an ERK1/2 Inhibitor (LY3214996) in Combination With Abemaciclib.
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2024-08-07
- Start Date:
- 2020-10-05
- Completion:
- 2023-08-07
Conditions
- Cancer
- Cancer Metastatic
- BRAF V600E
- MEK1 Gene Mutation
- MEK2 Gene Mutation
- ERK Mutation
- RAF1 Gene Mutation
Interventions
- DRUG